PedAM
Pediatric Disease Annotations & Medicines
| Disease | bacteremia |
| Phenotype | C0376545|hematologic malignancies |
| Sentences | 6 |
| PubMedID- 23219670 | Methods: we conducted a matched case-control study to investigate factors associated with p aeruginosa bacteremia in patients with hematologic malignancies. |
| PubMedID- 26064718 | Schroeteri bacteremia in patients with hematologic malignancies and neutropenia and only 18 documented cases in any population. |
| PubMedID- 23625018 | bacteremia developed mainly in patients with hematologic malignancies (56%). |
| PubMedID- 24729981 | The present study showed a significant incidence of vref bacteremia among patients with solid and hematologic malignancies as previously described in other studies [9, 10, 18, 19]. |
| PubMedID- 20052728 | Multivariate analysis revealed that breakthrough bacteremia was associated with hematologic malignancies and neutropenia (odds ratios, 9.9 and 3.0, respectively). |
| PubMedID- 26485570 | Consistent with our study, cornejo-juárez et al., indicated the increased risk of esbl-escherichia coli bacteremia in patients with hematologic malignancies who had prior cephalosporins exposure [29]. |
Page: 1